Effects of apolipoprotein E phenotypes on the neuropsychological functions of community-dwelling elderly individuals without dementia

Neuroscience Letters

Volumn 289, Issue 3, 2000, Pages 230-234

  Chey, Jeanyung ^a   Kim, Jong Won ^b   Cho, Hye Youn ^a  

^a Department of Psychology   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Aging; Apolipoprotein E phenotypes; Cognition; Dementia; Memory; Neuropsychological function; Visuo spatial function

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; COGNITION; COMMUNITY; FEMALE; GENE FREQUENCY; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; NEUROPSYCHOLOGY; PHENOTYPE; PRIORITY JOURNAL; RATING SCALE;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; DEMENTIA; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034637040     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01288-X     Document Type: Article

References (21)

1. Bondi M.W., Salmon D.P., Monsch A.U., Galasko D., Butters N., Klauber M.R., Thal L.J., Saitoh T. Episodic memory changes are associated with the APOE-ε4 allele in non-demented older adults. Neurology. 45:1995;2203-2206.
2. Chey, J., Korean-Dementia Rating Scale, Hakjisa, Seoul, 1998, 52 pp.
3. Chey, J., Detection of the dementia of the Alzheimer's type in the elderly Korean population utilizing neuropsychological tests, Paper presented at the 6th Asia/Oceania Regional Congress of Gerontology, June 1999, Seoul, South Korea.
4. Chey J., Na D.R., Park S., Park E., Lee S. Effects of education in dementia assessment: Evidence from standardizing the Korean-Dementia Rating Scale. Clin. Neuropsychol. 13:1999;293-302.
5. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test: Adult Version. 1987;The Psychological Corporation, San Antonio, TX.
6. Farrer L.A. Familial risk for Alzheimer disease in ethnic minorities. Arch. Neurol. 57:2000;28-29.
7. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., Van Dujin C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. J. Am. Med. Assoc. 278:1997;1349-1356.
8. Feskens E.J.M., Havekes L.M., Kalmijn S., De Knijff P., Launer L.J., Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. Br. Med. J. 309:1994;1202-1206.
9. Freedman M., Kaplan E., Delis D., Morris R. Clock Drawing: A Neuro-psychological Analysis. 1994;230 Oxford University Press, New York.
10. Helkala E.L., Koivisto K., Hanninen T., Vanhanen M., Kervinen K., Kuusisto J., Mykkanen L., Kesaniemi Y.A., Laakso M., Riekkinen P. The association of apolipoprotein E polymorphism with memory: a population based study. Neurosci. Lett. 191:1995;141-144.
11. Helkala E.L., Koivisto K., Hanninen T., Vanhanen M., Kervinen K., Kuusisto J., Mykkanen L., Kesaniemi Y.A., Laakso M., Riekkinen P. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci. Lett. 204:1996;177-180.
12. Jonker C., Schmand B., Lindeboom J., Havekes L.M., Launer L.J. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch. Neurol. 55:1998;1065-1069.
13. Ki C.S., Na D.L., Kim J.W., Kim H.J., Kim D.K., Yoon B.K. No association between the genes for butyrycholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am. J. Med. Genet. 88:1999;113-115.
14. Kim H.H., Na D.R. Korean-Boston Naming Test. 1997;52.
15. McKhann G., Drachman D., Folstein M.F., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
16. Milberg W.P., Hebben N., Kaplan E. The Boston Process Approach to neuropsychological assessment. Grant I., Adams K.M. Neuropsychological Assessment of Neuropsychiatric Disorders. 1996;58-80 Oxford University Press, New York.
17. Reed T., Carmelli D., Swan G.E., Breitner J.C.S., Welsh K.A., Jarvik G.P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch. Neurol. 51:1994;1189-1192.
18. Sano M., Devanand D.P., Richards M., Miller L.W., Marder K., Bell K., Dooneief G., Bylsma F.W., Lafleche G., Albert M., Folstein M., Stern Y. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol. 52:1995;961-966.
19. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., Kostner G.M. Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin. Genet. 50:1996;293-299.
20. Strimatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M.A., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
21. Talbot C.E., Lendon C., Craddock N., Shears S., Morris J.C., Goate A. Protection against Alzheimer's disease with apoE ε2. Lancet. 343:1994;1432-1433.